Recent Transactions

28-Oct-24
$1.8 billion (CAD value)
Canada flag
Target: 

Xplore Inc.

flag not available

Advised the Ad Hoc Crossover Group to Xplore on its CBCA Restructuring of C$1.8 billion of Secured Debt

03-Oct-24
$1.1 billion
United Kingdom flag
Target: 

Tyman plc

United States flag
Acquiror: 
Quanex Building Products Corporation

Advised Tyman plc, a leading international supplier of fenestration components and access solutions to the construction industry, on the recommendation of a cash and share acquisition by Quanex, a global NYSE listed manufacturing company serving OEMs in the fenestration, cabinetry, solar, refrigeration and outdoor products markets

19-Sep-24
$550 million
Canada flag
Target: 

Tacora Resources, Inc.

United States flag
Acquiror: 
O’Brien-Staley Partners, Millstreet Capital Management LLC, Brigade Capital Management LP, Cargill Incorporated

Advised Tacora Resources, a high-grade iron ore producer in Canada, on its CCAA Sale Process and Restructuring of $550 million of liabilities

28-Aug-24
Pending
Undisclosed
United Kingdom flag
Target: 

EthosEnergy

United States flag
Acquiror: 
One Equity Partners

Advised One Equity Partners, a middle market private equity firm, on the acquisition of EthosEnergy, a global independent turbine and rotating equipment service provider for power and process industries and for aerospace & defense markets

26-Jun-24
Pending
$630 million
Euro flag
Target: 

Haleon plc’s Nicotine Replacement Therapy Business (ex-US)

India flag
Acquiror: 
Dr. Reddy’s Laboratories

Advising Haleon plc on the sale of its global nicotine replacement therapy business (ex-US) to Dr. Reddy’s Laboratories

20-Jun-24
Pending
$1.8 billion
United States flag
Target: 

CP Kelco

United Kingdom flag
Acquiror: 
Tate & Lyle

Advising Tate & Lyle plc, a UK-listed specialty food and beverage ingredients company, on the acquisition of CP Kelco, a US-based provider of pectin, speciality gums and other nature-based ingredients, from J.M. Huber Corporation

30-May-24
Pending
Undisclosed
Netherlands, UK flags
Target: 

Renewi plc’s UK Municipal Business

United Kingdom flag
Acquiror: 
Biffa Limited

Advising Renewi plc, a leading European waste-to-product company, on the divestiture of its UK Municipal operations to Biffa Limited, a leading UK-wide integrated waste management business

09-Apr-24
Undisclosed
United States flag
Target: 

Tegra’s Operating Entities in Honduras, El Salvador, and the U.S.

Korea flag
Acquiror: 
SAE-A Trading

Advising Tegra, a premier and leading near and onshore apparel manufacturer for sport, team, and performance apparel, on the sale of its operating entities in Honduras, El Salvador, and the U.S. to SAE-A Trading, a vertically integrated textile and apparel garment manufacturer

05-Apr-24
$820 million (AUD)
Australia flag
Target: 

illion Australia Pty Ltd

United Kingdom flag
Acquiror: 
Experian Plc

Advising Experian Plc, the world’s leading global information services company, on the acquisition of  illion Australia Pty Ltd, one of Australasia's leading consumer and commercial credit bureaus

14-Feb-24
Undisclosed
United Kingdom flag
Target: 

Huntswood CTC Limited

Acquiror: 
The Results Companies, LLC

Advised Huntswood CTC Limited, a business process and outsourcing company, on its sale to The Results Companies, LLC (“ResultsCX”), a global Customer Experience Management company backed by ChrysCapital

11-Jan-24
Undisclosed
Target: 

ElectraMeccanica

United States flag
Acquiror: 
Xos

Advising ElectraMeccanica on its all-stock merger with Xos, a leading manufacturer of battery electric commercial vehicles

10-Aug-23
Undisclosed
United Kingdom flag
Target: 

Clinigen Ltd’s portfolio of Established Medicines

United Kingdom flag
Acquiror: 
CNX Therapeutics

Advised Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of a portfolio of Established Medicines to CNX Therapeutics, a UK-based European pharma company owned by Inflexion Partners

14-Jul-23
$674 million
U.S.A., U.K. flags
Target: 

Juice Plus+

flag not available

Advised Juice Plus+, a global health and wellness company in the direct selling space on a comprehensive recapitalization transaction

14-Jul-23
$333 million
Canada flag
Target: 

Canopy Growth Corporation

flag not available
Acquiror: 
N/A

Advised Canopy Growth, a leading diversified cannabis company, on a series of agreements, including privately negotiated redemption agreements with certain holders of its unsecured senior notes due July 15, 2023 and agreements with certain of its lenders under its term loan credit agreement dated March 18, 2021, that will have the overall effect of deleveraging the Company’s balance sheet by ~C$437mm over time

13-Jul-23
$224 million
Target: 

Distribuidora Internacional Carmen SAU

United States flag
Acquiror: 
Diploma PLC

Advised Diploma PLC in the acquisition of  Distribuidora Internacional Carmen SAU (“DICSA”),  a market-leading distributor of fluid power solutions into the European aftermarket

20-Jun-23
Pending
$595 million
United Kingdom flag
Target: 

Lookers Plc

Canada flag
Acquiror: 
Alpha Auto Group

Advising JerseyCo, the indirect Holdco of Alpha Auto Group, a Canadian automotive dealership group, on its acquisition of Lookers Plc, a leading UK automotive dealership group

01-Jun-23
$90.4 million
Canada flag
Target: 

PCAS Canada Inc.

Japan flag
Acquiror: 
DIC Corporation

Advised DIC Corporation, a Japanese specialty chemical company, on the acquisition of PCAS Canada Inc., a contract manufacturer of high-quality photoresist polymers, from PCAS SA, a French manufacturer of complex molecules for Life Sciences and Specialty Chemicals markets which is a majority-owned subsidiary of SK Capital-backed Seqens

27-Apr-23
$403 million
Netherlands flag
Target: 

Distrelec BV

United Kingdom flag
Acquiror: 
RS Group plc

Advised RS Group plc on the acquisiton of Distrelec, a high-service, digital-led distributor of industrial MRO and electronic products

25-Apr-23
Pending
Undisclosed
United Kingdom flag
Target: 

Kyowa Kirin International’s testosterone replacement therapy drug, Tostran®

United Kingdom flag
Acquiror: 
Advanz Pharma (UK)

Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on the divestiture of its testosterone replacement therapy drug, Tostran®, to Advanz Pharma, a privately-held, specialty pharmaceutical company

05-Apr-23
Pending
$185 million
Australia flag
Target: 

Calibre Group’s QuadR Business

Canada flag
Acquiror: 
WSP Global Inc.

Advising Calibre Group, an Australian diversified engineering group, on the sale of its Calibre QuadR business to WSP Global Inc., a leading global engineering and professional services firm

20-Mar-23
Pending
Undisclosed
Target: 

Clinigen Ltd’s Lamda Laboratories

Germany flag
Acquiror: 
Adragos Pharma

Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Lamda Laboratories, a European contract development business, to Adragos Pharma, a Munich-based pharmaceutical CDMO

07-Mar-23
Undisclosed
United Kingdom flag
Target: 

David Brown Santasalo

United States flag
Acquiror: 
Stellex Capital Management

Advised N4 Partners on the sale of David Brown Santasalo (DBS), UK based industrial gear manufacturer, to Stellex Capital Management

16-Feb-23
Pending
$220 million
U.S.A., U.K. flags
Target: 

Flavor Specialty Ingredients division of IFF

United Kingdom flag
Acquiror: 
Exponent Private Equity

Sole financial adviser to Exponent, one of the UK’s leading private equity firms, on the acquisition of IFF’s Flavor Specialty Ingredients division, a global leader in the base aromas market

23-Jan-23
Pending
$200 million
United Kingdom flag
Target: 

Clinigen Ltd’s Proleukin

United States flag
Acquiror: 
Iovance Biotherapeutics

Advising Clinigen Ltd, a UK-based global pharmaceutical services company and portfolio company of Triton Partners, on the sale of Proleukin (Interleukin-2 (Aldesleukin)), to Iovance Biotherapeutics, a late-stage biotechnology company developing novel T cell-based cancer immunotherapies

24-Nov-22
Pending
Undisclosed
Target: 

Kyowa Kirin International’s established medicines business

Germany flag
Acquiror: 
Grünenthal

Advising Kyowa Kirin International, a subsidiary of Kyowa Kirin Co., Ltd, a Japanese global specialty pharma company, on a collaboration agreement with Grünenthal GmbH, a global, science-based, privately-owned pharmaceutical company

Pages

show all